Literature DB >> 8863878

The changing panorama of cerebral palsy in Sweden. VII. Prevalence and origin in the birth year period 1987-90.

B Hagberg1, G Hagberg, I Olow, L von Wendt.   

Abstract

This seventh Swedish population-based cerebral palsy (CP) report comprises 216 children born between 1987 and 1990. The crude live birth prevalence was 2.36 per 1000, indicating a break in the continuous increase since 1970. Excluding 10 postnatally-derived cases, gestational-age specific prevalences were 80 for extremely, 54 for very and 8 for moderately preterms and 1.4 for term children per 1000. Birth weight-specific prevalences were 57 for birth weights < 1000 g, 68 for 1000-1499 g, 14 for 1500-2499 g and 1.4 for > or = 2500 g per 1000. The aetiology was considered prenatal in 8%, peri/neonatal in 54% and unclassifiable in 38% of preterms and 33, 28 and 39% of term children. Hemiplegic, diplegic and tetraplegic syndromes accounted for 22, 66 and 7% of preterms and 44, 29 and 10% of term children. Non-walking, mental retardation, epilepsy, severe visual impairment and infantile hydrocephalus were present in 39, 39, 26, 18 and 23% of preterms; and 38, 44, 36, 14 and 5% of term children, respectively. The entire series of 1408 cases born in 1954-90 revealed three distinct trend eras for preterms, clearly related to changes in perinatal care and shifts in type of CP manifestations.

Entities:  

Mesh:

Year:  1996        PMID: 8863878     DOI: 10.1111/j.1651-2227.1996.tb14193.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  29 in total

Review 1.  The term diplegia should be abandoned.

Authors:  A F Colver; T Sethumadhavan
Journal:  Arch Dis Child       Date:  2003-04       Impact factor: 3.791

2.  The spectrum of cerebral visual impairment as a sequel to premature birth: an overview.

Authors:  Gordon N Dutton
Journal:  Doc Ophthalmol       Date:  2013-05-10       Impact factor: 2.379

3.  Increasing rates of cerebral palsy across the severity spectrum in north-east England 1964-1993. The North of England Collaborative Cerebral Palsy Survey.

Authors:  A F Colver; M Gibson; E N Hey; S N Jarvis; P C Mackie; S Richmond
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-07       Impact factor: 5.747

4.  Trends in cerebral palsy.

Authors:  E Blair
Journal:  Indian J Pediatr       Date:  2001-05       Impact factor: 1.967

5.  Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain.

Authors:  P Gressens; S Marret; J M Hill; D E Brenneman; I Gozes; M Fridkin; P Evrard
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

6.  Influence of gestational age on nosologic CP characteristics in a high-risk population.

Authors:  Eveline Himpens; Ann Oostra; Inge Franki; Patrick Calders; Piet Vanhaesebrouck; Christine Van den Broeck
Journal:  Eur J Pediatr       Date:  2009-07-16       Impact factor: 3.183

Review 7.  Long-term outcome of preterm infants and the role of neuroimaging.

Authors:  Eliza Myers; Laura R Ment
Journal:  Clin Perinatol       Date:  2009-12       Impact factor: 3.430

8.  Prognostic value of brain proton MR spectroscopy and diffusion tensor imaging in newborns with hypoxic-ischemic encephalopathy treated by brain cooling.

Authors:  G Ancora; C Testa; S Grandi; C Tonon; F Sbravati; S Savini; D N Manners; L L Gramegna; G Tani; E Malucelli; L T Corvaglia; G Faldella; R Lodi
Journal:  Neuroradiology       Date:  2013-05-24       Impact factor: 2.804

9.  An algorithm for identifying and classifying cerebral palsy in young children.

Authors:  Karl C K Kuban; Elizabeth N Allred; Michael O'Shea; Nigel Paneth; Marcello Pagano; Alan Leviton
Journal:  J Pediatr       Date:  2008-06-02       Impact factor: 4.406

10.  Usefulness of an early neurofunctional assessment in predicting neurodevelopmental outcome in very low birthweight infants.

Authors:  O Picciolini; M L Giannì; C Vegni; M Fumagalli; F Mosca
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-03       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.